19-55762699-C-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001145014.2(RFPL4A):c.388C>A(p.Gln130Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001145014.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 4AN: 151068Hom.: 0 Cov.: 33 FAILED QC
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000574 AC: 8AN: 1394362Hom.: 0 Cov.: 71 AF XY: 0.00000872 AC XY: 6AN XY: 687782
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000265 AC: 4AN: 151068Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 73802
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.388C>A (p.Q130K) alteration is located in exon 3 (coding exon 2) of the RFPL4A gene. This alteration results from a C to A substitution at nucleotide position 388, causing the glutamine (Q) at amino acid position 130 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at